New Delhi [India], January 3 (ANI): All India Institute of Medical Sciences (AIIMS) director Dr Randeep Guleria on Sunday clarified that approval of COVAXIN, Bharat Biotech's COVID-19 vaccine is for an emergency situation and not emergency use authorisation which is given to Serum Institute
New Delhi [India], January 3 (ANI): Drugs Controller General of India (DCGI) on Sunday said the permission given to Bharat Biotech's COVAXIN is "for restricted use in an emergency situation" and it is given in "public interest as an abundant precaution" as the vaccine is still in clinical tr
Noida (Uttar Pradesh) [India], January 3 (ANI): Kumar Kundan, a journalist who volunteered for human trials of Bharat Biotech's Covid vaccine, refuted rumours about the side effects of "Covaxin" as the Drugs Controller General of India (DCGI) has finally given approval for the vaccine agains
Hyderabad (Telangana) [India], January 3 (ANI): Soon after Prime Minister Narendra Modi applauded the scientists for obtaining emergency use approval from Drugs Controller General of India (DCGI) for indigenous vaccines against COVID-19 on Sunday, the developer of Covaxin, Bharat Biotech,
New Delhi [India], January 3 (ANI): Hours after Drugs Controller General of India (DCGI) approved restricted use in an emergency situation to Bharat Biotech's COVID-19 vaccine, Indian Council of Medical Research (ICMR) on Sunday said data generated through pre-clinical studies and various ph
New Delhi [India], January 3 (ANI): Delhi Chief Minister Arvind Kejriwal congratulated people as the Drugs Controller General of India (DCGI) given approval for the emergency use of two vaccines on Sunday.
New Delhi [India], January 3 (ANI): Senior Congress leader Shashi Tharoor on Sunday said that the emergency approval to COVID-19 vaccine--Covaxin is premature and could be dangerous as it is still under phase 3 trial. He urged Union Health Minister Dr Harsh Vardhan to wait till full trials o
New Delhi [India], January 3 (ANI): As the country is eagerly waiting for the COVID-19 vaccination programme to begin, Dr Manoj Kumar, senior cardiologist at Max Hospital, New Delhi said that in the first phase, almost 30 crore population will be covered.
New Delhi [India], January 2 (ANI): With an expert panel of Drugs Controller General of India (DCGI) recommending grant of restricted emergency use authorisation to Bharat Biotech's indigenously developed COVID-19 vaccine on Saturday, doctors said it was a good development as the vaccine i
Hyderabad (Telangana) [India], January 2 (ANI): Bharat Biotech has recruited 23,000 volunteers so far for the Phase III clinical trials of its COVID-19 vaccine candidate, 'COVAXIN'.
New Delhi [India], January 2 (ANI): An expert panel of Drugs Controller General of India (DCGI) has recommended granting restricted emergency use authorisation to Bharat Biotech's indigenously developed COVID-19 vaccine, also known as Covaxin, government sources told ANI on Saturday.
Hyderabad (Telangana) [India], December 31 (ANI): The government could evaluate two vaccines including the indigenously researched Covaxin and AstraZeneca to address the Covid-19 pandemic, Dr Vijay Bhaskar, Chairman of the Ethics Committee, Clinical trials and research said on Thursday.